Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease
View Patent ↗Describe herein is a CATT-tetranucleotide repeat polymorphism at position −817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays. Four genotypes are described which comprise 5, 6, 7, or 8-CATT repeat units. Of these, the 5-CATT allele has the lowest level of basal and stimulated MIF promoter activity in vitro. The presence of the low expressing, 5-CATT repeat allele correlated with low disease severity in a cohort of rheumatoid arthritis patients. Methods, compositions and apparatus for detecting this CATT-tetranucleotide repeat polymorphism at position −817 of the human Mif gene, and for using same for assessing predisposition to severe inflammatory disease, are also disclosed.
1. A method of detecting a CATT tetranucleotide repeat polymorphism in the promoter of the human macrophage inhibitory factor gene, SEQ ID NO: 12, wherein the CATT tetranucleotide repeat begins at position 259 of SEQ ID NO: 12, comprising:
amplifying the promoter with a PCR primer set,
analyzing the size of the amplified product to determine how many CATT tetranucleotide repeats are present, and
detecting 5, 7 or 8 CATT tetranucleotide repeats.
2. The method of claim 1 wherein said PCR primer set is SEQ ID NO: 1 and SEQ ID NO: 2.
3. The method of claim 1 wherein said PCR primer set is SEQ ID NO: 1 and SEQ ID NO: 9.